As of June 21, 2025, Athenex Inc (ATNX) reports a Graham Number of 4.23.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Athenex Inc's Graham Number
Over recent years, Athenex Inc's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2022-12-31 | 4.23 |
| 2021-12-31 | 4.23 |
This trend highlights how Athenex Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Athenex Inc's Graham Number to Peers
To better understand Athenex Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Athenex Inc (ATNX) | 4.23 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
| Eagle Pharmaceuticals Inc (EGRX) | 33.30 |
Compared to its competitors, Athenex Inc's Graham Number is among the lowest compared to peers, which may indicate relative fundamental weakness by Graham's criteria.